Biosimilar Newsletter Archive

41. 10.08.20 -- Biosimilar News You May Have Missed During COVID-19 10/8/2020
    10/08/20 Biosimilar Development Newsletter
42. 10.06.20 -- New Podcast Episodes: Data Quality For FDA Submissions, CMC Considerations For FIH Studies, And More 10/6/2020
    10/06/20 Biosimilar Development Newsletter
43. 10.05.20 -- Seasoned Experts Share Their Perspectives On GMP, CMC, And The FDA 10/5/2020
    10/05/20 Biosimilar Development Newsletter
44. 10.01.20 -- Sandoz: Critical Initiatives For A New Biosimilars Generation 10/1/2020
    10/01/20 Biosimilar Development Newsletter
45. 09.24.20 -- Celltrion's Bioinnovatives Shaking Up Biosimilars 9/24/2020
    09/24/20 Biosimilar Development Newsletter
46. 09.17.20 -- Sandoz President: Managing The COVID-19 Biologics Supply Chain 9/17/2020
    09/17/20 Biosimilar Development Newsletter
47. 09.16.20 -- Deliberations/Considerations/Pathways To Achieve Viral Preparedness 9/16/2020
    09/16/20 Biosimilar Development Newsletter
48. 09.10.20 -- Oncology Biosimilars: Prepare For A Non-Buy & Bill World 9/10/2020
    09/10/20 Biosimilar Development Newsletter
49. 09.03.20 -- Cardinal Health VP Reveals Biosimilar Uptake Goals 9/3/2020
    09/03/20 Biosimilar Development Newsletter
50. 09.01.20 -- New Podcast Episodes: Bolt Biotherapeutics On Fundraising; RNAi Beyond The Liver; Myeloid Cells In Immuno-Oncology 9/1/2020
    09/01/20 Biosimilar Development Newsletter